» Articles » PMID: 36386199

Changes in Mental Health, Wellbeing and Personality Following Ayahuasca Consumption: Results of a Naturalistic Longitudinal Study

Overview
Journal Front Pharmacol
Date 2022 Nov 17
PMID 36386199
Authors
Affiliations
Soon will be listed here.
Abstract

Naturalistic and placebo-controlled studies suggest ayahuasca, a potent psychedelic beverage originating from Indigenous Amazonian tradition, may improve mental health, alter personality structure, and reduce alcohol and drug intake. To better understand ayahuasca's therapeutic potential and to identify factors that influence therapeutic efficacy, we conducted a naturalistic, longitudinal study of facilitated ayahuasca consumption in naïve participants using a comprehensive battery of self-report questionnaires. Ayahuasca naive individuals registering for ayahuasca ceremonies were asked to complete a range of validated questionnaires assessing mental health, alcohol/cannabis use, relationships, personality, and connection to self and spirituality, prior to and 1 month after attending an ayahuasca ceremony. Data for two mental health measures (the DASS-21 and PANAS) and acute subjective effects the MEQ-30 were also assessed 7 days post-ceremony. Repeated measures ANOVA were used to examine pre-to-post changes, and Pearson correlations explored predictors of improvement in outcomes. Fifty-three attendees (32 women, 21 men) completed pre and post ayahuasca assessments with 55.6% of the sample reporting a complete mystical experience based on the MEQ-30. One-month post-ayahuasca, significant reductions were identified in depression, anxiety, stress, alcohol and cannabis use, body dissociation, accepting external influence, self-alienation, impulsivity, and negative affect/emotionality. Significant increases were identified in positive mood, self-efficacy, authentic living, extraversion, agreeableness, open-mindedness, spirituality, and satisfaction with relationships. While facets of the mystical experience held little predictive validity on outcome measures, baseline traits, particularly high negative emotionality and body dissociation, and low sense of self-efficacy, robustly predicted improvements in mental health and alcohol/cannabis use, and alterations in personality structure which are linked to better mental health. This study suggests facilitated ayahuasca consumption in naïve participants may precipitate wide-ranging improvements in mental health, relationships, personality structure, and alcohol use. Associations between baseline traits and therapeutic improvements mark an important first step toward personalized, precision-based medicine and warrant randomized controlled trials to confirm and elaborate on these findings. Longitudinal, observational studies and randomized clinical control trials suggest ayahuasca may exert therapeutic effects on mental health and alcohol/cannabis use, and alter personality structure. However, it is unclear if improvements are diagnosis-specific and factors that predict therapeutic gains have yet to be extensively elucidated. This longitudinal, observational study examined the effects of facilitated ayahuasca consumption in naive participants on mental health, alcohol and substance use/abuse, personality traits, relationships, and connection to self and spirituality. We found wide-ranging improvements 1-month post-treatment across these domains, and identified baseline traits which predict pre-to-post changes on primary outcome measures. Improvements were not diagnostic-specific, suggesting ayahuasca may be generally efficacious. Personality traits, body dissociation, and self-efficacy were strong predictors of therapeutic improvements, marking an important first step toward personalized, precision-based medicine. Randomized controlled trials are warranted to confirm and elaborate on these findings.

Citing Articles

A prospective ecological momentary assessment study of an ayahuasca retreat: exploring the salutary impact of acute psychedelic experiences on subacute affect and mindfulness skills in daily life.

Sznitman S, Behar Y, Dicker-Oren S, Shochat T, Meiri D, Butto N Psychopharmacology (Berl). 2025; 242(3):545-561.

PMID: 39825910 PMC: 11861408. DOI: 10.1007/s00213-024-06704-8.


Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelics.

Chaves C, Dos Santos R, Dursun S, Tusconi M, Carta M, Brietzke E Front Psychiatry. 2024; 15:1485337.

PMID: 39568756 PMC: 11576444. DOI: 10.3389/fpsyt.2024.1485337.


Ayahuasca: A review of historical, pharmacological, and therapeutic aspects.

Ruffell S, Crosland-Wood M, Palmer R, Netzband N, Tsang W, Weiss B PCN Rep. 2024; 2(4):e146.

PMID: 38868739 PMC: 11114307. DOI: 10.1002/pcn5.146.


Psilocybin-induced changes in neural reactivity to alcohol and emotional cues in patients with alcohol use disorder: an fMRI pilot study.

Pagni B, Petridis P, Podrebarac S, Grinband J, Claus E, Bogenschutz M Sci Rep. 2024; 14(1):3159.

PMID: 38326432 PMC: 10850478. DOI: 10.1038/s41598-024-52967-8.


Associations between the use of psychedelics and other recreational drugs with mental health and resilience during the COVID-19 pandemic.

Balaet M, Trender W, Hellyer P, Hampshire A Front Psychiatry. 2023; 14:1184681.

PMID: 37398594 PMC: 10307955. DOI: 10.3389/fpsyt.2023.1184681.


References
1.
Thomas G, Lucas P, Capler N, Tupper K, Martin G . Ayahuasca-assisted therapy for addiction: results from a preliminary observational study in Canada. Curr Drug Abuse Rev. 2013; 6(1):30-42. DOI: 10.2174/15733998113099990003. View

2.
Riba J, Romero S, Grasa E, Mena E, Carrio I, Barbanoj M . Increased frontal and paralimbic activation following ayahuasca, the pan-Amazonian inebriant. Psychopharmacology (Berl). 2006; 186(1):93-8. DOI: 10.1007/s00213-006-0358-7. View

3.
Doering-Silveira E, Grob C, de Rios M, Lopez E, Alonso L, Tacla C . Report on psychoactive drug use among adolescents using ayahuasca within a religious context. J Psychoactive Drugs. 2005; 37(2):141-4. DOI: 10.1080/02791072.2005.10399794. View

4.
Barbosa P, Giglio J, Dalgalarrondo P . Altered states of consciousness and short-term psychological after-effects induced by the first time ritual use of ayahuasca in an urban context in Brazil. J Psychoactive Drugs. 2005; 37(2):193-201. DOI: 10.1080/02791072.2005.10399801. View

5.
James E, Keppler J, Robertshaw T, Sessa B . N,N-dimethyltryptamine and Amazonian ayahuasca plant medicine. Hum Psychopharmacol. 2022; 37(3):e2835. PMC: 9286861. DOI: 10.1002/hup.2835. View